182 related articles for article (PubMed ID: 23163753)
1. Increased prolidase activity and oxidative stress in PCOS.
Hilali N; Vural M; Camuzcuoglu H; Camuzcuoglu A; Aksoy N
Clin Endocrinol (Oxf); 2013 Jul; 79(1):105-10. PubMed ID: 23163753
[TBL] [Abstract][Full Text] [Related]
2. Serum prolidase activity and oxidative stress markers in pregnancies with intrauterine growth restricted infants.
Toy H; Camuzcuoglu H; Arioz DT; Kurt S; Celik H; Aksoy N
J Obstet Gynaecol Res; 2009 Dec; 35(6):1047-53. PubMed ID: 20144170
[TBL] [Abstract][Full Text] [Related]
3. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
4. [Study on the oxidative stress in the ovaries of a rat model of polycystic ovary].
Gong J; Wu DB; Zhang LL; Li J; Zhao X; Zhang D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):238-42, 247. PubMed ID: 25924437
[TBL] [Abstract][Full Text] [Related]
5. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
[TBL] [Abstract][Full Text] [Related]
6. Serum prolidase activity and oxidative-antioxidative status in Legg-Calve-Perthes disease.
Altay MA; Erturk C; Aksoy N; Taskin A; Bilge A; Celik H; Isikan UE
J Pediatr Orthop B; 2011 Jul; 20(4):222-6. PubMed ID: 21304409
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
[TBL] [Abstract][Full Text] [Related]
8. A preliminary study pointing out the role of serum prolidase activity and oxidative-antioxidative status parameters during the treatment process of patients with idiopathic clubfoot.
Altay MA; Erturk C; Aksoy N; Taskın A; Isıkan UE
Scand J Clin Lab Invest; 2011 Nov; 71(7):576-82. PubMed ID: 21834619
[TBL] [Abstract][Full Text] [Related]
9. The effects of metformin on endothelial dysfunction, lipid metabolism and oxidative stress in women with polycystic ovary syndrome.
Kocer D; Bayram F; Diri H
Gynecol Endocrinol; 2014 May; 30(5):367-71. PubMed ID: 24517721
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered.
Torun AN; Vural M; Cece H; Camuzcuoglu H; Toy H; Aksoy N
Gynecol Endocrinol; 2011 Dec; 27(12):988-92. PubMed ID: 21557696
[TBL] [Abstract][Full Text] [Related]
11. Inappropriate gonadotropin secretion in polycystic ovary syndrome.
Hsu MI; Liou TH; Liang SJ; Su HW; Wu CH; Hsu CS
Fertil Steril; 2009 Apr; 91(4):1168-74. PubMed ID: 18325508
[TBL] [Abstract][Full Text] [Related]
12. The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS.
Uncu G; Sözer MC; Develioğlu O; Cengiz C
Gynecol Endocrinol; 2002 Dec; 16(6):447-52. PubMed ID: 12626031
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
Liou TH; Yang JH; Hsieh CH; Lee CY; Hsu CS; Hsu MI
Fertil Steril; 2009 Dec; 92(6):1960-5. PubMed ID: 18980763
[TBL] [Abstract][Full Text] [Related]
14. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress in nonobese women with polycystic ovary syndrome: correlations with endocrine and screening parameters.
Verit FF; Erel O
Gynecol Obstet Invest; 2008; 65(4):233-9. PubMed ID: 18196905
[TBL] [Abstract][Full Text] [Related]
16. Plasma selenium levels in Turkish women with polycystic ovary syndrome.
Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536
[TBL] [Abstract][Full Text] [Related]
17. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease.
Fenkci V; Fenkci S; Yilmazer M; Serteser M
Fertil Steril; 2003 Jul; 80(1):123-7. PubMed ID: 12849813
[TBL] [Abstract][Full Text] [Related]
18. Oxidative Stress And Prolidase Enzyme Activity In The Pathogenesis Of Primary Varicose Veins.
Akar İ; İnce İ; Aslan C; Benli İ; Demir O; Altındeger N; Dogan A; Ceber M
Vascular; 2018 Jun; 26(3):315-321. PubMed ID: 29216795
[TBL] [Abstract][Full Text] [Related]
19. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
20. Prolidase activity and oxidative stress in patients with major depressive disorder.
Kokacya MH; Bahceci B; Bahceci I; Dilek AR; Dokuyucu R
Psychiatr Danub; 2014 Dec; 26(4):314-8. PubMed ID: 25377365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
